Clinical Trials Browser

Phase 3 × Glioblastoma × pembrolizumab × Clear all

NCT06556563 2026-03-13

EF-41

Phase 3 Recruiting

Glioblastoma

NCT06749925 2025-04-01

Clinical Trial Assessing the Efficacy and Safety of Dendritic Cell-Based Immunotherapy for Glioblastoma

Phase 3 Not yet recruiting

Glioblastoma